Tsumura & Co.:企業の戦略・SWOT・財務情報

◆英語タイトル:Tsumura & Co. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1947
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tsumura & Co. – Strategy, SWOT and Corporate Finance Report
Summary

Tsumura & Co. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Tsumura & Co. (Tsumura or ‘the company’) is engaged in the manufacturing and sale of pharmaceutical products, including primarily prescription Kampo products. The company operates in Japan, China, South Korea and other countries. It is headquartered in Tokyo, Japan and employed 3,242 people as of March 31, 2016.

Scope

- Detailed information on Tsumura & Co. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Tsumura & Co. in the form of a SWOT analysis
- An in-depth view of the business model of Tsumura & Co. including a breakdown and examination of key business segments
- Intelligence on Tsumura & Co.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Tsumura & Co., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Tsumura & Co. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Tsumura & Co. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Tsumura & Co.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Tsumura & Co.: Company Overview 8
Tsumura & Co.: Overview and Key Facts 8
Tsumura & Co.: Overview 8
Tsumura & Co.: Key Facts 8
Tsumura & Co.: Key Employees 9
Tsumura & Co.: Key Employee Biographies 10
Tsumura & Co.: Major Products and Services 12
Tsumura & Co.: Company History 13
Tsumura & Co.: Management Statement 15
Tsumura & Co.: Locations and Subsidiaries 16
Tsumura & Co.: Key Competitors 17
Tsumura & Co.: Company Analysis 18
Tsumura & Co.: Business Description 18
Tsumura & Co.: SWOT Analysis 19
Tsumura & Co.: SWOT Overview 19
Tsumura & Co.: Strengths 19
Tsumura & Co.: Weaknesses 20
Tsumura & Co.: Opportunities 20
Tsumura & Co.: Threats 22
Tsumura & Co.: Corporate Financial Deals Activity 23
Tsumura & Co.: Financial Deals Overview 23
Tsumura & Co.: Targets and Partners 25
Tsumura & Co.: Top Deals 2014 – 2018YTD* 26
Tsumura & Co.: Advisors 27
Tsumura & Co.: Top Financial Advisors 27
Tsumura & Co.: Capital Raising 28
Tsumura & Co.: Partnership 29
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: Tsumura & Co.: Key Facts
Table 2: Tsumura & Co.: Key Employees
Table 3: Tsumura & Co.: Locations and Subsidiaries
Table 4: Tsumura & Co.: Key Competitors
Table 5: Tsumura & Co.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Tsumura & Co.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Tsumura & Co.: Targets and Partners
Table 8: Tsumura & Co.: Top Deals 2014 - 2018YTD*
Table 9: Tsumura & Co.: Financial Advisor Ranking by Value (US$m)
Table 10: Tsumura & Co.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: Tsumura & Co.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: Tsumura & Co.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Tsumura & Co.: Partnership Trend by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: Tsumura & Co.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Tsumura & Co.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Tsumura & Co.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: Tsumura & Co.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: Tsumura & Co.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Tsumura & Co.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Tsumura & Co.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Escalon Medical Corp (ESMC)-医療機器分野:企業M&A・提携分析
    Summary Escalon Medical Corp (Escalon) is a medical device company with focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachymeters, co …
  • The Arag Group:企業の戦略・SWOT・財務分析
    The Arag Group - Strategy, SWOT and Corporate Finance Report Summary The Arag Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hummingbird Diagnostics GmbH:企業の製品パイプライン分析
    Summary Hummingbird Diagnostics GmbH (Hummingbird), is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates and analyzes genomic biomarkers especially …
  • Mercantil Bank, N.A.:企業の戦略・SWOT・財務情報
    Mercantil Bank, N.A. - Strategy, SWOT and Corporate Finance Report Summary Mercantil Bank, N.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TX Holdings Inc (TXHG):企業の財務・戦略的SWOT分析
    Summary TX Holdings Inc (TX Holdings) is a diversified company. The company provides rail products and mining supplies. It offers rail products such as rail, rail chart, turnouts, track accessories, tools, and others. TX Holdings provides mining supplies such as miner bits, roof bit assemblies, bloc …
  • Exxon Mobil Corporation:企業の戦略・SWOT・財務情報
    Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report Summary Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • FibroStatin SL:製薬・医療:M&Aディール及び事業提携情報
    Summary FibroStatin SL (FibroStatin) is a drug development company that focuses on the development of treatment candidates for drug resistant lung cancer and idiopathic pulmonary fibrosis. The company’s pipeline products include T12/FST12 for NSCLC, GPBP-Mab/FSM26 for idiopathic pulmonary fibrosis a …
  • China Petrochemical Development Corporation (1314):企業の財務・戦略的SWOT分析
    China Petrochemical Development Corporation (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Calgro M3 Holdings Ltd:企業の戦略・SWOT・財務情報
    Calgro M3 Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Calgro M3 Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Khatam al-Anbia:企業の戦略的SWOT分析
    Khatam al-Anbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • General Electric Co (GE)-医療機器分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Biocad:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocad is a biotechnology company that conducts research and development services. The company develops, manufactures and distributes generic pharmaceutical products. It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases t …
  • Fuji Pharma Co Ltd (4554):企業の財務・戦略的SWOT分析
    Summary Fuji Pharma Co Ltd (Fuji Pharma) develops, manufactures, and commercializes pharmaceutical products. The company specializes in offering injection agents, drugs for external use, internal drugs, and diagnostic products among others. It also provides medical care products for women, acute med …
  • Genworth Financial, Inc.:企業のM&A・事業提携・投資動向
    Genworth Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genworth Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Agappe Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Agappe Diagnostics Ltd (Agappe) is an in-vitro diagnostic company that offers biochemistry products. The company offers biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; point of care, urinalysis and auxiliary products. Its biochemis …
  • Windtree Therapeutics Inc (WINT):医療機器:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Immunomic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomic Therapeutics Inc (ITI) is a clinical-stage biotechnology company that develops patented lysosomal-associated membrane protein or lamp technology based nucleic acid immunotherapy platforms. The company’s vaccines utilize the body’s natural biochemistry to develop immune response inc …
  • TAXIS Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a biopharmaceutical company that treats, reduce and eliminates the threat of current and emergent antimicrobial resistance across a range of infectious diseases. It research new classes of antibiotic agents to treat life-threatening and multidrug-r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆